These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7507413)

  • 81. Hepatotoxicity of agents that enhance formation of focal hepatocellular proliferative lesions (putative preneoplastic foci) in a rapid rat liver bioassay.
    Ward JM; Tsuda H; Tatematsu M; Hagiwara A; Ito N
    Fundam Appl Toxicol; 1989 Jan; 12(1):163-71. PubMed ID: 2925015
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study.
    Lemmer ER; Vessey CJ; Gelderblom WC; Shephard EG; Van Schalkwyk DJ; Van Wijk RA; Marasas WF; Kirsch RE; Hall Pde L
    Carcinogenesis; 2004 Jul; 25(7):1257-64. PubMed ID: 14988222
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump.
    Eldridge SR; Tilbury LF; Goldsworthy TL; Butterworth BE
    Carcinogenesis; 1990 Dec; 11(12):2245-51. PubMed ID: 2265476
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats.
    Harada T; Maronpot RR; Morris RW; Stitzel KA; Boorman GA
    Toxicol Pathol; 1989; 17(4 Pt 1):579-93. PubMed ID: 2483465
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Wy-14,643, a peroxisome proliferator, inhibits compensative cell proliferation and hepatocyte growth factor mRNA expression in the rat liver.
    Motoki Y; Tamura H; Watanabe T; Suga T
    Cancer Lett; 1999 Jan; 135(2):145-50. PubMed ID: 10096422
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
    Grasl-Kraupp B; Waldhör T; Huber W; Schulte-Hermann R
    Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
    Schulte-Hermann R; Kraupp-Grasl B; Bursch W; Gerbracht U; Timmermann-Trosiener I
    Toxicol Pathol; 1989; 17(4 Pt 1):642-9; discussion 649-50. PubMed ID: 2576472
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
    Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Induction of hepatic ornithine decarboxylase by hypolipidemic drugs with hepatic peroxisome proliferative activity.
    Izumi K; Reddy JK; Oyasu R
    Carcinogenesis; 1981; 2(7):623-7. PubMed ID: 7273341
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis.
    Zhu H; Wang Y; Chen J; Cheng G; Xue J
    Exp Mol Pathol; 2004 Feb; 76(1):44-50. PubMed ID: 14738868
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator.
    Hosokawa S; Tatematsu M; Aoki T; Nakanowatari J; Igarashi T; Ito N
    Carcinogenesis; 1989 Dec; 10(12):2237-41. PubMed ID: 2686852
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats.
    Tsuda H; Ozaki K; Uwagawa S; Yamaguchi S; Hakoi K; Aoki T; Kato T; Sato K; Ito N
    Jpn J Cancer Res; 1992 Nov; 83(11):1154-65. PubMed ID: 1336490
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS; Lalwani ND; Watanabe TK; Reddy JK
    Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, Wy-14,643 and clofibric acid.
    Marsman DS; Swanson-Pfeiffer CL; Popp JA
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):1-6. PubMed ID: 8378924
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Phenotypic alteration of hepatocellular foci in rats treated with clofibrate and phenobarbital.
    Hasegawa R; Yoshida T; Mizoguchi Y; Futakuchi M; Kim DJ; Cui L; Ito N
    Cancer Lett; 1994 Aug; 83(1-2):89-95. PubMed ID: 8062238
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years.
    Cattley RC; Conway JG; Popp JA
    Cancer Lett; 1987 Dec; 38(1-2):15-22. PubMed ID: 3690505
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats.
    Hayashi F; Tamura H; Watanabe T; Suga T
    Cancer Lett; 1995 May; 92(1):87-90. PubMed ID: 7757964
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Carcinogenicity of captafol in F344/DuCrj rats.
    Tamano S; Kurata Y; Kawabe M; Yamamoto A; Hagiwara A; Cabral R; Ito N
    Jpn J Cancer Res; 1990 Dec; 81(12):1222-31. PubMed ID: 2125991
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Isoenzyme shift from glucokinase to hexokinase is not an early but a late event in hepatocarcinogenesis.
    Klimek F; Bannasch P
    Carcinogenesis; 1993 Sep; 14(9):1857-61. PubMed ID: 8403210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.